FDA to Review Fosamax

Posted on September 7, 2011

On Friday, September 9, two panels of the United States Food and Drug Administration will meet to discuss the drug Fosamax and its long term use, and whether the drug should have time restrictions placed on its usage, requiring users to stop using it for certain lengths of time during treatment, according to news reports.

A study that suggested bisphosphonate drugs like Fosamax increases the users risk of suffering femur fractures was released in July, which prompted this safety review.

The FDA first issued a warning that using these drugs would increase your risk of atypical femur fractures in October of 2010, but thousands of lawsuits have been filed against Merck, the manufacturer of Fosamax, by users who state the company failed to warn consumers of the dangers of consuming the product.

As a Los Angeles personal injury attorney, if you or a loved one has been injured because of Fosamax I suggest you seek medical attention right away. It can also be just as important to contact a product liability lawyer as soon as possible because you may be entitled to monetary compensation as a result of getting injured because of a defective or recalled product. You should also remember that the longer you take to contact someone about your case the more chance you have to lose evidence.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields